Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Laplaud DA, Casey R, Barbin L, Debouverie M, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Lubetzki C, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Wahab A, Labauge P, Magy L, Defer G, Guennoc AM, Maubeuge N, Labeyrie C, Patry I, Nifle C, Casez O, Michel L, Rollot F, Leray E, Vukusic S, Foucher Y; SFSEP and OFSEP groups.

Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12.

PMID:
31300547
2.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Créange A, Labauge P, Magy L, Defer G, Foucher Y, Laplaud DA; CFSEP and OFSEP groups.

Neurology. 2016 Feb 23;86(8):771-8. doi: 10.1212/WNL.0000000000002395. Epub 2016 Jan 29.

3.

Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.

Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, Ruet A, Debouverie M, Le Page E, Casez O, Heinzlef O, Stankoff B, Bourre B, Castelnovo G, Rico A, Berger E, Camdessanche JP, Defer G, Clavelou P, Al Khedr A, Zephir H, Fromont A, Papeix C, Brochet B, Pelletier J, Lebrun C; Club Francophone de la Sclérose en Plaques Investigators.

JAMA Neurol. 2014 Apr;71(4):436-41. doi: 10.1001/jamaneurol.2013.6240.

PMID:
24566807
4.

[Prognostics factors of renal failure in multiple sclerosis].

Viart L, Elalouf V, Petit J, Al Khedr A, Kristkowiak P, Saint F.

Prog Urol. 2012 Dec;22(16):1026-32. doi: 10.1016/j.purol.2012.08.271. Epub 2012 Sep 16. French.

PMID:
23178100
5.

Methylprednisolone-induced immune thrombocytopenia.

Royer B, Lee K, Gruson B, Roszkiewicz F, Al Khedr A, Colson A, Camboulives A, Bierling P, Marolleau JP.

Blood. 2010 Jul 1;115(26):5431-2. doi: 10.1182/blood-2010-01-264986. No abstract available.

6.

Teaching NeuroImages: marked reduced apparent diffusion coefficient in acute multiple sclerosis lesion.

Bugnicourt JM, Garcia PY, Monet P, Bonnaire B, Al Khedr A, Godefroy O.

Neurology. 2010 May 18;74(20):e87. doi: 10.1212/WNL.0b013e3181df09f7. No abstract available.

PMID:
20479354
7.

Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease.

Masse I, Bordet R, Deplanque D, Al Khedr A, Richard F, Libersa C, Pasquier F.

J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1624-9.

8.

[Infectious myelopathies: clinical, serological, and prognostic patterns].

Ramirez C, de Seze J, Delalande S, Michelin E, Ferriby D, Al Khedr A, Stojkovic T, Destée A, Vermersch P.

Rev Neurol (Paris). 2004 Nov;160(11):1048-58. French.

PMID:
15602347
9.

[Acute upper limb ischemia in a young adult without cardiac disease. Value of transesophageal echocardiography].

Sal R, Cormier JM, Chapoutot L, Alamé A, al-Khedr A, Raynaud JC, Apparuit JP, Bailly L.

Arch Mal Coeur Vaiss. 1996 Oct;89(10):1317-21. French.

PMID:
8952832

Supplemental Content

Loading ...
Support Center